Gapped up hitting a new 52-week high with a volume-driven gain on the prior session, getting more extended from any sound base. The prior mid-day report noted - "Found support above its 50 DMA line and above previously noted resistance in the $24 area during its recent consolidation. Earnings increases in the 3 most recent quarterly comparisons through Dec '14 have been at or above the +25% minimum guideline (C criteria) following a streak of negative comparisons. Annual earnings (A criteria) history has been strong and steady. Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead."
Gapped up hitting a new 52-week high with a volume-driven gain today, getting more extended from any sound base. Found support above its 50 DMA line and above previously noted resistance in the $24 area during its recent consolidation. Earnings increases in the 3 most recent quarterly comparisons through Dec '14 have been at or above the +25% minimum guideline (C criteria) following a streak of negative comparisons. Annual earnings (A criteria) history has been strong and steady. Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead.
Hitting a new 52-week high with a volume-driven gain today, getting extended after recently wedging above previously noted resistance in the $24 area. Earnings increases in the 3 most recent quarterly comparisons through Dec '14 have been at or above the +25% minimum guideline (C criteria) following a streak of negative comparisons. Annual earnings (A criteria) history has been strong and steady. Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead.
Challenging its 52-week high and prior resistance in the $24 area with a streak of 6 consecutive gains. There is no resistance remaining due to overhead supply. Earnings increases in the 3 most recent quarterly comparisons through Dec '14 have been at or above the +25% minimum guideline (C criteria) following a streak of negative comparisons. Annual earnings (A criteria) history has been strong and steady.
Enduring distributional pressure while recently challenging its 52-week high. There is no resistance remaining due to overhead supply. Found support at its 50 DMA line recently while building an orderly base above its prior base. Prior mid-day reports cautioned - "Earnings increases in recent quarterly comparisons have been strong but with sub par sales revenues, and its annual earnings (A criteria) history has not been strong and steady."
Enduring distributional pressure while recently challenging its 52-week high. There is no resistance remaining due to overhead supply. Found support at its 50 DMA line recently while building an orderly base above its prior base. Prior mid-day reports cautioned - "Earnings increases in recent quarterly comparisons have been strong but with sub par sales revenues, and its annual earnings (A criteria) history has not been strong and steady."
Retreating on higher volume today after challenging its 52-week high. There is no resistance remaining due to overhead supply. Found support at its 50 DMA line recently while building an orderly base above its prior base. Prior mid-day reports cautioned - "Earnings increases in recent quarterly comparisons have been strong but with sub par sales revenues, and its annual earnings (A criteria) history has not been strong and steady."
Retreating from new 52-week and multi-year highs hit this week. There is no resistance remaining due to overhead supply, however the 9/13/12 mid-day report noted - "Earnings increases in recent quarterly comparisons have been strong but with sub par sales revenues, and its annual earnings (A criteria) history has not been strong and steady."
Earnings increases in recent quarterly comparisons have been strong but with sub par sales revenues, and its annual earnings (A criteria) history has not been strong and steady. Rallied to new 52-week and multi-year highs and there is no resistance remaining due to overhead supply.
On 10/31/07 announced plans to be acquired by MAPFRE SA.